November 2, 2017 / 9:56 PM / 17 days ago

BRIEF-T2 Biosystems Q3 loss per share $0.45

Nov 2 (Reuters) - T2 Biosystems Inc

* T2 biosystems reports third quarter 2017 financial results and provides company update

* Q3 loss per share $0.45

* Sees q4 revenue $1.1 million to $1.3 million

* Q3 earnings per share view $-0.49 -- Thomson Reuters I/B/E/S

* Q3 revenue $1.1 million versus i/b/e/s view $1.1 million

* T2 biosystems inc - ‍company reaffirms expectations regarding timeframe for fda clearance of t2bacteria panel​

* T2 biosystems inc - ‍continues to prepare for commercial launch of t2bacteria panel in u.s. As early as year-end, pending market clearance by fda.​

* T2 biosystems inc - ‍cash and cash equivalents as of sept 30 with additional remaining liquidity on term loan , should extend cash runway into h1 2019​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below